Publications and Resources
RM Partners provides a range of publications and resources, including reports, guidance and protocols, to inform healthcare professionals and patients about cancer care and services. Many of the resources and documents produced by the London Cancer Alliance that are still current are available here. Others are available at the archived London Cancer Alliance website.
- RM Partners Cancer Strategy for North West and South West London 2021-2025
The RM Partners Cancer Strategy 2021-2025 describes our long-term vision in how we will deliver more patients being diagnosed at an earlier stage and increasing survival following a diagnosis of cancer. The strategy has been developed with all our stakeholders, including the two integrated care systems that we cover (North West London and South West London) and aligns compatibly with their long-term strategic aims for us to deliver collaboratively comprehensive cancer care across each system.
- RM Partners Annual Review 2018/19
RM Partners Annual Review 2018/19 showcases our projects looking at improving early detection, and enabling faster diagnosis and treatment. Additionally, with more patients than ever living with and beyond cancer, we feature our work aimed at supporting health and well-being which in turn can help to optimise quality of life.
- RM Partners Annual Review 2017/18
The RM Partners Annual Review celebrates our transformational cancer work across west London. The review contains a number of examples that illustrate the positive impact our work is having on improving care and experience for people affected by cancer.
- Frontier Economics early diagnosis interventions evaluation June 2020
An external evaluation of the RM Partners early diagnosis interventions programme by Frontier Economics and NatCen Social Research, has demonstrated our success in improving cancer services and developing a strong network of organisations.
- Ipsos Mori early diagnosis interventions evaluation November 2019
An external evaluation of the RM Partners Transformation Fund intervention projects by Ipsos Mori and York Health Economics Consortium has demonstrated our success in delivering improvements in earlier detection and faster diagnosis of cancer.
- Cancer Vanguard Evaluation
As part of the national Cancer Vanguard, RM Partners worked with external evaluators from Technopolis Group and Optimity Advisors to determine the impact of its work on cancer outcomes and patient experience; the value delivered across all three Vanguard partners; and whether the work can be replicated. The purpose was not to determine a ‘one size fits all’ model of care but rather to identify opportunities to learn from the work of the Vanguard and spread this learning nationally amongst the other 16 Cancer Alliances. There is also an Executive Summary and an Illustrative Summary.
- National Cancer Strategy
The NHS England National Cancer Strategy, Achieving World-Class Cancer Outcomes, was published in 2015 by the Independent Cancer Taskforce. The report set out a vision for what cancer patients should expect from the health service. Cally Palmer, National Cancer Director for England, launched a plan to make these changes a reality by 2020, including the establishment of 19 Cancer Alliances across the country to lead implementation of the strategy locally.
- NHS Long Term Plan
The NHS Long Term Plan, first published in January 2019, was developed in partnership with frontline health and care staff, patients and their families and other experts. It sets out ways that the NHS can achieve the ambitious improvements it wants to to see for patients over the next ten years.
- Pan London urgent referral forms: The Transforming Cancer Services Team has produced Pan-London Suspected Cancer Referral Forms. These replace the suspected cancer referral forms produced by the former cancer networks. The forms, educational resources and support information are available from Healthy London Partnership.